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Chronic hepatitis C is characterized by metabolic disorders and by a microenvironment
in the liver dominated by oxidative stress, inflammation and regeneration processes
that can in the long term lead to liver cirrhosis and hepatocellular carcinoma. Several
lines of evidence suggest that mitochondrial dysfunctions play a central role in these
processes. However, how these dysfunctions are induced by the virus and whether
they play a role in disease progression and neoplastic transformation remains to be
determined. Most in vitro studies performed so far have shown that several of the
hepatitis C virus (HCV) proteins also localize to mitochondria, but the consequences
of these interactions on mitochondrial functions remain contradictory and need to be
confirmed in the context of productively replicating virus and physiologically relevant
in vitro and in vivo model systems. In the past decade we have been proposing a
temporal sequence of events in the HCV-infected cell whereby the primary alteration
is localized at the mitochondria-associated ER membranes and causes release of
Ca2+ from the ER, followed by uptake into mitochondria. This ensues successive
mitochondrial dysfunction leading to the generation of reactive oxygen and nitrogen
species and a progressivemetabolic adaptive response consisting in decreased oxidative
phosphorylation and enhanced aerobic glycolysis and lipogenesis. Here we resume
the major results provided by our group in the context of HCV-mediated alterations of
the cellular inter-compartmental calcium flux homeostasis and present new evidence
suggesting targeting of ER and/or mitochondrial calcium transporters as a novel
therapeutic strategy.
Keywords: HCV, mitochondria associated membranes (MAM), calcium channels, viroporin, oxidative
phosphorylation, redox signaling
INTRODUCTION
Liver disease related to HCV infection represents a major health burden worldwide (Di Bisceglie,
1998). Recent estimates suggest around 71 million chronically infected individuals, i.e., 1% of
the world population (Cf. WHO Global Hepatitis Report 2017 | http://www.who.int/hepatitis/
publications/global-hepatitis-report2017/en/). Approximately 80% of acutely infected individuals
develop chronic infection which may progress to cirrhosis in 2–20% after 20 years and in
15–30% after 30 years. Once cirrhosis is established, the risk of hepatocellular carcinoma (HCC)
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development is 1–5% per year (Alter and Seeff, 2000). Great
progress has been achieved in the treatment of chronic hepatitis C
in recent years. Currently available directly acting antivirals yield
sustained virologic response rates>90%, with very well-tolerated
and relatively short treatment regimens (Pawlotsky et al., 2015).
HCV is a positive strand RNA virus belonging to the
Flaviviridae family and Hepacivirus genus discovered in 1989
(Choo et al., 1989). It infects hepatocytes, with the main steps
of its life cycle involving: binding to membrane receptors and
entry into the cell host; uncoating of the genome from the viral
capsid; translation of the viral genome at the ER; replication and
assembly; as well as release of the virus particles (Moradpour
et al., 2007). Notably, HCV replication and virion assembly takes
place in a specialized lipid-enriched cellular compartment of the
infected host called membranous web (Dubuisson et al., 2002). It
is important to remind that HCV is not cytolytic.
MITOCHONDRIAL OXIDATIVE
METABOLISM IN HCV INFECTION
The 9.6-kb HCV genome harbors a long open reading frame
which is translated into a polyprotein of about 3000 amino acids.
This is processed at the level of the ER by cellular and viral
proteases to generate 10 proteins. Three of them (structural—
core, E1, and E2) contribute to the virus particle, the others
(non-structural—p7, NS2, NS3, NS4A, NS4B, NS5A, NS5B) are
functional proteins necessary for replication and assembly of the
virion (Moradpour and Penin, 2013).
It is amazing how such a limited number of proteins
is sufficient to reroute host cell physiology to promote
establishment of the infection and viral propagation. An example
is given by the capability of HCV to evade innate immunity. This
relies in part on the activation of MAVS (mitochondrial antiviral
signaling protein) which is anchored on the mitochondrial outer
membrane and that after binding of RIG-1 provides a recruiting
platform for a number of factors whose activation leads to
expression of interferon-β (Seth et al., 2005; West et al., 2011).
One of the two viral proteases, the NS3-4A protease, cleaves
MAVS, thereby impairing interferon induction (Li et al., 2005;
Meylan et al., 2005; Bellecave et al., 2010). The involvement
of mitochondria in the viral life cycle is even more pervasive.
Indeed, HCV proteins were found to localize at contact sites
between the ER and the mitochondrial compartment and move
by lateral trafficking to the mitochondrial outer membrane
(Mottola et al., 2002; Schwer et al., 2004; Griffin et al., 2005;
Kasprzak et al., 2005; Suzuki et al., 2005; Nomura-Takigawa et al.,
2006; Rouillé et al., 2006; Ripoli et al., 2010; Horner et al., 2011).
The ER-mitochondria contact sites, also known as mitochondria
associated membranes (MAMs) (Mannella et al., 1998; Rizzuto
et al., 1998), are a well-organized intracellular synapse-like inter-
organelle communicating systems whose structural tethering
components have been elucidated (Raturi and Simmen, 2013;
Giorgi et al., 2015; Giacomello and Pellegrini, 2016). The
main proposed function of MAMs is to provide a tightly
controlled, localized flux of calcium from the ER store into
mitochondria without raising its concentration in the cytosol
(Rizzuto and Pozzan, 2006; Krols et al., 2016). Calcium is
a recognized physiological modulator of the mitochondrial
metabolism, though above a threshold level it becomes cytotoxic
(Duchen, 2000).
On this background, we have investigated functional
properties of mitochondria in the context of HCV infection.
To this aim we used two well-established in vitro cell models.
One is a tetracycline-regulated system allowing the inducible
expression of the entire HCV polyprotein or of defined parts
thereof in stably transfected U-2 OS human osteosarcoma
cells (Moradpour et al., 1998); in the inducible system only
transcription and translation of the viral proteins occurs. The
other is an infective system where the virus accomplishes its
entire life cycle in the permissive HCC-derived cell line Huh-7.5;
to track infected cells GFP was inserted into the HCV genome
(Moradpour et al., 2004; Schaller et al., 2007).
The main results of systematic studies carried over the
past decade by our group are schematically illustrated in
Figure 1 (Piccoli et al., 2007; Ripoli et al., 2010; Quarato
et al., 2012, 2014). It is shown that expression of the
HCV proteins both in the inducible system and in Huh
7.5 cells transfected with infectious full-length HCV leads to
profound alterations of the mitochondrial functions. These
comprise: (i) intra-mitochondrial calcium (mtCa2+) overload;
(ii) dissipation of the mitochondrial membrane potential (19m),
which correlates with inhibition of cell respiration and complex
I (NADH dehydrogenase) activity; (iii) overproduction of
reactive oxygen and nitrogen species (RO/NS). Time-resolved
analysis demonstrated that mtCa2+ overload was the earliest
mitochondria-related alteration following induction of HCV
protein expression (Piccoli et al., 2007; Quarato et al., 2012).
INHIBITORS OF THE
INTRA-MITOCHONDRIAL CA2+ FLUX
DAMPEN HCV-MEDIATED
MITOCHONDRIAL DYSFUNCTION
The major transporter of Ca2+ into mitochondria is the
mitochondrial calcium uniporter (MCU) (De Stefani et al., 2011).
MCU is part of a complex, comprising also regulatory subunits,
mediating a 19m-driven accumulation of calcium ions on the
negative site of the inner mitochondrial membrane (Marchi and
Pinton, 2014; Granatiero et al., 2017). From the kinetic point
of view, MCU is a very low-affinity, high-capacity transporter,
meaning that though possessing a relatively high Km for Ca2+
its abundance in the inner mitochondrial membranes makes
mitochondria an efficient buffering compartment preventing
harmful Ca2+ rising in the cytosol (Deryabina et al., 2004).
The kinetic limitation of MCU is overcome by MAMs, which
releasing ER-calcium in its intermembrane space provides a
relatively high-concentration Ca2+ microdomain (Rizzuto and
Pozzan, 2006). The ER possesses a number of calcium releasing
channels comprising inositol trisphosphate (IP3) and ryanodine
receptors (Patterson et al., 2004; Hamilton, 2005).
Importantly, when cells inducibly expressing the HCV
polyprotein were treated with ruthenium red (RR) or Ru360,
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FIGURE 1 | Overview of the alterations in mitochondrial physiology linked to HCV protein expression and of drug-targetable ion channels and translocators. The
contact site between endoplasmic reticulum and mitochondria is shown (mitochondrial associated membrane, MAM). HCV proteins are shown in purple on the ER
membrane (ERM) and on the outer mitochondrial membrane (OMM) where they are likely transferred from ERM by lateral diffusion. Interaction of HCV proteins with the
ERM-located Ca2+ transporters (RyR/IP3R) is shown, causing localized increase of the [Ca2+], thereby promoting its uptake within the mitochondria via the
voltage-dependent anion channel (VDAC) and the mitochondrial calcium uniporter (MCU) located in the OMM and IMM respectively. The viroporin HCV p7 is also
shown to contribute to the mitochondrial Ca2+ load. Activation of the ER unfolded protein response (UPR) linked to the stressing accumulation of HCV proteins might
also be indirectly involved in the deregulation of the inter-organelle Ca2+ fluxes (not shown). The increased intramitochondrial [Ca2+] affects components of the
respiratory chain (RC) and activates mitochondrial nitric oxide synthase (not shown, but see text), thereby increasing generation of reactive oxygen and nitrogen
species (RO/NS). RC is illustrated within the IMM cristae with complexes I, III, IV (from right to left). The FoF1 H
+-ATP synthase is also shown in the upper part of the
crista. Electron transfer from NADH to O2 (forming H2O) and the chemiosmotic circuitry coupling RC proton pumping to the 19-driven ATP synthesis are shown by
black arrowed lines. Electron leak from dysfunctional RC leads to ROS formation/accumulation (red arrowed lines) which is mitigated by the concerted action of
Mn-superoxidase dismutase 2 (SOD2), catalase (CAT) and glutathione peroxidase (GPX) with glutathione reductase (GR) and nicotinamide nucleotide
transhydrogenase (NNT) needed to regenerate reduced glutathione (GSH) at expense of NADPH. The enhanced intramitochondrial levels of Ca2+ and RO/NS are
shown to activate the permeability transition pore (PTP), illustrated schematically by the cyclophilin D (CyP D)-mediated assembly of OMM and IMM components.
Opening of the PTP causes flush out of low molecular weight metabolites comprising NAD(P)+/NAD(P)H and GSH/GSSG. This leads to further impairment of the RC
activity (and of the oxidative phosphorylation) and to reduced ROS scavenging with consequent worsening of the redox balance. RO/NS are finally shown to affect the
activity of the Ca2+ transporting system (green arrow) with further entry of Ca2+ into the mitochondria, thereby fuelling a positive feedback mechanism. Blocking the
above-illustrated cycle of alterations constitutes a rationale to develop therapeutic strategies. Accordingly, inhibitors of the ER Ca2+ channel(s) (dantrolene), the
viroporin p7 (amantadine), the MCU (ruthenium red/Ru360), the PTP (aciclovir) are shown. Reproduced with modifications from Quarato et al. (2013). Copyright
(2013), with permission from Elsevier.
both inhibitors of the MCU (Broekemeier et al., 1994; Matlib
et al., 1998), the above-reported mitochondrial alterations were
fully prevented (Piccoli et al., 2007). A similar protection
was observed when these cells were treated with dantrolene,
an inhibitor of the ER calcium channels (Piccoli et al.,
2007).
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Taken together, the results obtained led us to suggest
a working model whereby the overload of mtCa2+ is the
seminal event in the successive alterations (Piccoli et al.,
2006, 2009; Quarato et al., 2013). Possibly, overcrowding of
HCV proteins at MAMs might affect the overall calcium
retention capacity of the ER membranes as a consequence
of a mild unfolded protein response (UPR) (Carreras-Sureda
et al., 2017) or elicit a specific effect on the Ca2+ channels
(Deniaud et al., 2008). The MCU-mediated load of Ca2+ into
the mitochondria drives alterations in the redox homeostasis.
This might be achieved by activation of a Ca2+-dependent
mitochondrial isoform of the nitric oxide synthase (Dedkova
et al., 2004; Ghafourifar and Sen, 2007). NO is known to affect
the mitochondrial respiratory chain by competitive inhibition
of the cytochrome c oxidase and/or by covalent modification
of complex I (Brown and Borutaite, 2004; Sarti et al., 2012).
Impairment of the normal electron transfer in the respiratory
chain results in enhanced electron leak to O2, with formation
of the superoxide anion (O•−2 ) (Murphy, 2009), which is further
converted to H2O2 by the Mn-SOD. To support this model is
the evidence provided by confocal microscopy analysis, using
specific probes for NO, O•−2 , and peroxides, showing a clear
compartmentalization of the fluorescent signals resembling the
mitochondrial network (Piccoli et al., 2007). Overproduction of
ROS has been recurrently reported to enhance mtCa2+ uptake
likely by modification of redox sensitive cysteines of the ER
calcium channels (Feissner et al., 2009; Görlach et al., 2015)
and/or of the MCU (Dong et al., 2017). Accordingly, treatment
of cells inducibly expressing the HCV polyprotein with the
antioxidant N-acetylcysteine (NAC) prevented completely the
mtCa2+ overload as well as inhibition of the mitochondrial
respiratory activity and of the 19m generation (Piccoli et al.,
2007).
The enhanced levels of Ca2+ and RO/NS into mitochondria
proved to activate a long established feature of the organelle
better known as mitochondria permeability transition (MPT)
(Giorgio et al., 2017). MPT consists in increased non-specific
conductance of the inner mitochondrial membrane to low
molecular weight molecules (<1,500 Da). Activation of the
MPT is attained by a number of factors promoting binding of
cyclophilin D (Cyp D) to the MPT pore (Elrod and Molkentin,
2013). The molecular nature of the MPT pore has been elusive
for a long time though recent evidence suggests the FoF1-ATP
synthase as a plausible candidate (Bernardi et al., 2015; Jonas
et al., 2015). Transient opening (i.e., flickering) of the MPT pore
works as a relief valve-like system avoiding hyperpolarization of
the inner mitochondrial membrane as well as recycling of Ca2+
(Aon et al., 2008; Nivala et al., 2011). Conversely, permanent
opening of the MPT pore causes exit of low molecular weight
antioxidants (like glutathione) and redox coenzymes fostering
oxidative stress as well as swelling of mitochondria because
of its hyperosmolarity as compared with the cytosol (Di Lisa
et al., 2001). This event can lead to autophagy of the organelle,
apoptosis or necrosis depending on the prevailing cellular setting
(Kroemer et al., 2007).
To verify the involvement of the MPT in the observed
HCV-mediated mitochondrial dysfunctions we tested the effect
of alisporivir, a robust antiviral drug (Paeshuyse et al., 2006;
Coelmont et al., 2009; Gallay and Lin, 2013). Alisporivir is a
cyclosporin A analog but without immunosuppressive properties
(Gallay and Lin, 2013). It binds to Cyp D, interfering with its
opener function of the MPT (Elrod and Molkentin, 2013). When
alisporivir was tested on the mitochondrial dysfunctions caused
by HCV protein expression we found an impressive capability of
the drug to fully prevent (and even reverse) the 19m collapse,
RO/NS production and mtCa2+ overload (Quarato et al., 2012).
Combination of all the above reported observations supports a
pathogenetic model for HCV infection whereby a self-nourishing
mechanism is activated, consisting in positive feed-back loops
initiated by the entry of Ca2+ into mitochondria and fuelled by
the ensuing RO/NS overproduction elicited by impaired activity
of the respiratory chain (Figure 1). In such a cascade of events
an essential role is seemingly played by mitochondrial and ER
transporters (i.e., MCU, MPT pore, ER-Ca2+ channels) since
inhibition of either of them prevents and reverses the HCV
protein-mediated mitochondrial alterations.
EXPLORING THE HCV VIROPORIN p7 AS A
POTENTIAL THERAPEUTIC TARGET
The impact of Ca2+ flux homeostasis in the interplay between
HCV and the host cell is also underlined by the presence in the
HCV proteins of the viroporin p7 (Madan and Bartenschlager,
2015). p7 is a transmembrane protein constituted by two
transmembrane helices which is thought to oligomerize in
hexameric structures, forming a channel (Clarke et al., 2006).
When inserted into artificial membranes, p7 proved to increase
ionic conductance with selectivity toward cations (Griffin
et al., 2003; Montserret et al., 2010; Wozniak et al., 2010). It
accumulates in ER membranes and is particularly enriched at
the MAMs sub-compartment (Griffin et al., 2004). Data obtained
in vitro suggested a role of the antiviral drug amantadine
in inhibiting HCV p7-mediated cation conductance (Griffin
et al., 2003; Cook et al., 2013; see also Atoom et al., 2014).
Given this premise and in keeping the observed mitochondrial
alterations caused by HCV protein expression we tested on those
the effects of amantadine, an adamantane-derived compound
(Figure 1). We found that amantadine not only prevented but
also rescued HCV protein-mediated mitochondrial dysfunction
in cells inducibly expressing the HCV polyprotein (Quarato
et al., 2014). Specifically, amantadine corrected: (i) overload of
mitochondrial Ca2+; (ii) inhibition of respiratory chain activity
and oxidative phosphorylation; (iii) reduction of membrane
potential; (iv) overproduction of reactive oxygen species. The
effects of amantadine were observed within 15min following
drug administration and confirmed in Huh-7.5 cells transfected
with the infectious full-length HCV genome. However, these
effects were also observed in cells expressing subgenomic HCV
constructs, indicating that they are not mediated or only in part
mediated by p7. Single organelle analyses carried out on isolated
mouse liver mitochondria demonstrated that amantadine
induces hyperpolarization of the membrane potential (Quarato
et al., 2014). Moreover, amantadine treatment increased the
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calcium threshold required to trigger mitochondrial permeability
transition opening (Quarato et al., 2014). These results
led to the conclusion that amantadine displays off-target
effects likely relatable to Ca2+ transporting systems of the
host cell.
METABOLIC REWIRING OF HOST CELL BY
HCV
Surprisingly, in spite of the overt impairment of the
mitochondrial respiratory chain activity and of the concurrent
oxidative phosphorylation (OxPhos), HCV-infected cells did
not show evident signs of sufferance or bioenergetic failure.
Indeed, the difference in growth rate and viability of both
HCV-induced U2-OS cells and HCV-infected Huh-7 cells
was negligible as compared with control cells. Accordingly,
the cellular ATP level was unaffected, if not increased, in
HCV-induced U2-OS cells grown in glucose-containing media
(Piccoli et al., 2007). Though this is consistent with the non-
cytopathic property of HCV, it implies the need to understand
how the virus rewires the host cell metabolism (Diamond et al.,
2010).
An important factor and regulator of metabolism in cells
challenged by stressing conditions is constituted by hypoxia
inducible factor 1α (HIF-1α) (Wang and Semenza, 1993).
HIF-1α is rapidly degraded under normal oxygen tension
following hydroxylation by O2- and 2-oxo-glutarate-dependent
prolyl hydroxylases (PDHs) (Bruick and McKnight, 2001).
The hydroxylated HIF-1α is then ubiquitinated and steered
toward proteasomal degradation (Mole et al., 2001). Conversely,
under hypoxic conditions the hydroxylation of HIF-1α is
dampened and it accumulates and moves to the nucleus where
promotes transcription of a number of prosurvival genes,
including those coding for glycolytic enzymes (Semenza et al.,
1994; Wang et al., 1995). However, conditions different from
hypoxia, which in turn inhibit PDH activity (i.e., RO/NS
and/or competing 2-oxo-acids) result in stabilization of HIF-
1α also under normoxia (Déry et al., 2005; Pugh, 2016;
Figure 2A).
We demonstrated that HIF-1α is stabilized under normoxic
conditions both in HCV-induced U2-OS and HCV-infected
Huh-7 cells as well as in patients’ liver biopsies (Ripoli et al.,
2010; see also Nasimuzzaman et al., 2007; Wilson et al., 2012).
Consistent with this finding, we showed that the HIF target genes
coding for the glycolytic enzymes hexokinases I and II (HKI,
HKII) were both upregulated at the transcriptional and protein
levels. This would indicate a metabolic shift toward aerobic
glycolysis that we supported by an observed higher release of
lactate in HCV-induced U2-OS cells (Figure 2B). It is worth
considering that HKII was shown to interact with the outer
mitochondrial membrane at the level of the voltage-dependent
anion channel (VDAC) and to preventMPT activation (Pastorino
et al., 2005; Chiara et al., 2008). Also, HKI was found to interact
with the outer mitochondrial membrane, thereby blocking
apoptotic signals (Abu-Hamad et al., 2008; Schindler and Foley,
2013).
On this basis, we proposed a model, consistent with other
reported evidence, whereby the MPT pore oscillates between
the closed and open state under the positive influence of HKII,
which restrains the effects of RO/NS and mtCa2+ (Quarato
et al., 2012). Stabilization of HIF-1α, up-regulating the expression
of HKII, is likely to be linked to activation of the AKT-
mTOR pathway (Land and Tee, 2007; Agani and Jiang, 2013).
Indeed it has been suggested that PI3K, the upstream activator
of AKT, binds the HCV NS5A protein which activates it
permanently (Street et al., 2005). Moreover, the active form of
AKT deactivates GSK-3β, which by phosphorylation of VDAC
displaces HKII, promoting permanent opening of the MPTP
under stressing conditions (Pastorino et al., 2005; see also Chiara
et al., 2008). In agreement with this proposal, we found that the
phosphorylation state of AKT and GSK-3β was enhanced both
in HCV-induced U2-OS and in HCV-transfected Huh 7.5 cells
(Figure 2D).
We have here a remarkable example of the strategy put in
action by HCV which although impairing the most important
energetic powerhouse of the cell (i.e., the mitochondrial OxPhos
system) at the same time tunes the consequent effects evading
premature cell-death signaling of the host cell.
INHIBITORS OF THE ER AND
MITOCHONDRIAL CA2+
CHANNEL/PORTER DAMPER
LIPOGENESIS IN HCV INFECTED CELLS
A recently emerged property of HCV is the enhanced mitophagy
in the host cell (Kim et al., 2013, 2014; Ruggieri et al.,
2014). Mitophagy is a selective autophagic degradation of
mitochondria which is part of a quality control processing
of the cell (Anding and Baehrecke, 2017). The main trigger
for recognizing damaged mitochondria is a drop in the
membrane potential which recruits and activates mitophagic
factors like PINK1 and parkin to initiate first the fission of
the mitochondrial network and then the engulfment of the
isolated mitochondria into isolation membranes to become
mitophagosomes (Zimmermann and Reichert, 2017). However,
and remarkably in the context of HCV infection, this process
appears to be somehow abortive since the mitophagosomes,
instead of fusing with lysosomes, have been reported to
accumulate, together with lipid droplets, in the membranous web
which is the peculiar environment where HCV RNA replication
takes place (Hara et al., 2014). Blocking this process results in
suppression of the viral replication (Fang et al., 2017). This is
possibly another strategy to hinder the MAVS-mediated immune
response.
Accumulation of lipid droplets can be easily detected by
staining cells with Oil Red O. Figure 3 shows the impressive
accumulation of lipid droplets in HCV-infected Huh 7.5 cells and
the co-localization of themwith GFP-labeledNS5AHCVprotein.
Similar results were obtained with HCV-induced U2-OS cells.
This observation clearly implies an HCV-mediated deregulation
of fatty acid metabolism, which may derive from an inhibition
of fatty acid oxidation (FAO) or increased fatty acid synthesis
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FIGURE 2 | HCV induces rewiring of cell metabolism in infected cells. (A) The scheme summarizes major changes in the metabolic pathways induced by HCV
infection as supported by evidence reported in the literature and by the unpublished results showed in panels (B–D) obtained in HCV Jc1 RNA-transfected Huh-7.5
cells in vitro. HCV protein-induced enhanced entry of Ca2+ into mitochondria is shown to dampen the respiratory chain activity and oxidative phosphorylation
(OxPhos) and to elicit increased reactive oxygen species (ROS) production. These inhibit the prolyl-hydroxylase (PHD) leading to stabilization of the hypoxia induced
transcription factor (HIF-1α) which controls the expression of the glycolytic enzymes, thereby shifting cell metabolism toward aerobic glycolysis. (B) shows the
stabilization of HIF-1α and the consequent metabolic shift evidenced by upregulation of the hexokinase I (HK-I) transcript and by increased lactate release in
transfected Huh-7.5 cells. The enhanced glycolytic flux leads to accumulation of pyruvate which proved to further inhibit PHD. Pyruvate enters into mitochondria
where it is converted in acetyl-CoA (AcCoA) by the pyruvate dehydrogenase (PDH). The HCV protein-mediated load of Ca2+ into mitochondria is shown to activate
the pyruvate dehydrogenase phosphate (PDP), which controls the activity of the PDH. To note, at the transcriptional level both PDH and PDP [but not the pyruvate
dehydrogenase kinase (PDK)] are significantly up-regulated in HCV RNA-transfected Huh-7.5 cells (C). The enhanced production of AcCoA leads to formation of
citrate (CIT), which because of the limited availability of oxidized NAD+ (caused by impaired respiratory chain activity) is not further transformed via the tricarboxylic
cycle and exits from mitochondria to shuttle AcCoA in the cytosol. The cytosolic AcCoA functions as precursor for the de novo synthesis of fatty acids (FA) that with
intermediates of glycolysis forms triglycerides (TG) accumulating as lipid droplets. (D) shows that HCV RNA-transfected Huh-7.5 cells displays a two-fold increased
expression of the acetyl CoA carboxylase (ACC), the controlling step in FA synthesis. ACC activity is controlled by its inactivating phosphorylation mediated by the
AMP-activated protein kinase (AMPK) which is in turn controlled by the phosphorylated state of Akt/protein kinase B. Phosphorylation of AKT is mediated by activation
of the phosphatidylinositol 3-kinase (PI3K), which has been reported to interact with HCV NS5A. Notably, the phosphorylated AKT is known to inactivate the glycogen
synthase kinase 3β (GSK3β) which inhibits the activity of the transcription factor sterol regulatory element-binding protein 1c (SREBP 1c) controlling the expression of
ACC. Consistently, the Western blots in panel (D) show enhanced phosphorylation of both AKT and GSK3β. The inability of HCV RNA-transfected to properly oxidize
FA by the mitochondrial β-oxidation (requiring efficient respiratory chain) may lead to cytosolic accumulation of acyl-CoA which flow into TG synthesis (not shown).
Lipid droplets results in formation of a membraneous web, contributed also by the HCV protein induced extensive rearrangement of host cell membranes, which
contains the sites of viral replication and possibly assembly.
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FIGURE 3 | Effect of ruthenium red and dantrolene on lipid droplet formation in transiently HCV RNA-transfected Huh-7.5 cells. Lipid droplets were stained with Oil
Red O (3 mg/ml for 60min) and imaged by laser scanning confocal microscopy. Representative images of control and Jc1-GFP RNA-transfected Huh-7.5 cells are
shown illustrating the merge of Oil Red O (red) and GFP-related (green) fluorescence signals; the latter was used to track HCV-transfected cells (>90% of the cell
population). Control Huh-7.5 cells were subjected to the transfection protocol but without HCV RNA. The time point after transfection was 72 h (see Ripoli et al., 2010
for further details). Where indicated 5µM Ruthenium red (RR) or 10µM dantrolene (DAN) were added soon after transfection. Enlargements of the merged pictures
are also shown to better visualize lipid droplets in HCV RNA-transfected Huh-7.5 cells. The histograms of the Oil Red O-related fluorescence in GFP-positive
transfected cells comparing untreated and drug-untreated cells are shown and refer to the averaged size and to the occupied cellular area fraction of the lipid droplets.
The fluorescence intensity was assessed by averaging 10–20 cells from each of at least 10 optical fields under each condition using ImageJ 1.49v (http://imagej.nih.
gov/ij). The average of four independent experiments plus the standard error of the mean (SEM), along with statistical analysis, is shown.
(FAS) or both. Deregulation of peroxisome proliferator-activated
receptors (PPARs), the master transcription factors regulating
lipid metabolism, is likely to be involved (Agriesti et al., 2012).
Notably, treatment of infected cells with either dantrolene or
RR prevented lipid droplet accumulation, pointing once again
to alteration of the ER-mitochondria calcium flux as a germinal
event in HCV infection.
Hampering of FAO can be envisioned as a consequence of the
HCV-mediated impairment of respiratory chain function which
limits the proper redox recycling of the coenzymes required
in fatty acid β-oxidation. In addition, flickering of the MPT
would result in progressive leakage from the mitochondrial
compartment of factors needed for FAO (like carnitine) (Di Lisa
et al., 2001).
However, also an enhanced fatty acid and triglyceride (TG)
biosynthesis is likely to occur concurrently with FAO dampening.
Consistently, we found up-regulation of the FAS rate-limiting
enzyme acetyl CoA carboxylase (Wakil et al., 1983; Kim,
1997) both in terms of enhanced expression and of post-
translational activating phosphorylation via the PI3K-AKT axis
(Hardie, 1989; Figure 2D). Activation of the transcription factor
SREBP1c, controlling the expression of ACC, is known to
be linked to the AKT-mediated inactivation of GSK-3β (Kim
et al., 2004; Park et al., 2009; Yecies et al., 2011). Such
a signaling pathway was recently found to upregulate HCV
RNA translation (Shi et al., 2016). Precursors for FAS and
TG are provided by glycolytic metabolites. Acetyl CoA is
largely derived by pyruvate oxidative decarboxylation, catalyzed
by the pyruvate dehydrogenase (PDH) complex, and via the
citrate shuttle released in the cytoplasm. The PDH function
is tightly controlled by its phosphorylation state, which in
turn depends on the balanced activities of a PDH kinase
(PDK) and a PDH phosphatase (PDP) (Roche et al., 2001).
To note, we found that HCV full-lenght RNA-transfected
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FIGURE 4 | Pathogenetic model of HCV-mediated alterations. The development of disease in patients with chronic hepatitis C is modeled as a function of the level of
the oxidative alteration and of the mt-Ca2+ load. Three pathogenic settings are presented. Low RO/NS- and mt-Ca2+-dependent stress level activates a pro-survival
and proliferative adaptive response by redox signaling. The flickering balance between the mitochondrial PTP closed/open configuration is set to a level that causes
collapse of the respiratory chain-mediated protonmotive force (i.e., 1µH+), with consequent impairment of ATP synthesis by the FoF1-H+ ATP synthase. This forces
the infected cell to shift its energy-supplying metabolism toward glycolysis by activation of the transcription factor HIF-1α. Collapse of the 1µH+ is a trigger for
selective removal of damaged mitochondria by the organelle-specific autophagic machinery (i.e., mitophagy), which is required for HCV replication. Such a prosurvival
setting in the host cell facilitates HCV persistence. However, if additional (mutagenic) hits accumulate over the time this may result in clonal expansion, leading to
hepatocellular carcinoma. Intermediate levels of RO/NS and mt-Ca2+ enhance the closed to open transition of the PTP causing, among others, depletion of
low-molecular weight metabolites (i.e., glutathione, NAD+, carnitine, coenzyme A) needed to guarantee antioxidant capacity and import of long chain acyl-CoA
(AcCoA) for β-oxidation. Accumulation of acyl-CoA leads to conversion into triglycerides (TG). Other factors, described in Figure 2 (i.e., activation of HIF-1α,
PI3K-Akt-ACC) and of the sterol regulatory element-binding protein (SREBP-1c) may contribute to enhanced de novo lipogenesis. All together this may account for
the steatosis which can be observed in HCV-infected hepatocytes. Accumulation of lipid droplets in the cytoplasm is believed to provide an assembly platform for
HCV. High intramitochondrial concentrations of Ca2+ and ROS induces permanent opening of the PTP causing osmotic swelling and rupture of the outer
mitochondria membrane. The consequent release of cytochrome c and other pro-apoptotic factors triggers the caspase cascade. Depending on the intracellular ATP
level, this would lead to apoptosis or necrosis activating, in the last case, tissue fibrosis. Reproduced with modifications from Quarato et al. (2013), Copyright (2013),
with permission from Elsevier.
Huh 7.5 cells displayed enhanced transcript levels of PDH
and PDP (Figure 2C). Remarkably, mtCa2+ is required to
stimulate the PDH phosphatase and consequently the PDH,
which is more active in its dephosphorylated state (Huang et al.,
1998; Denton, 2009). This notion would explain the observed
inhibition of lipid droplet accumulation in HCV-infected cells
when treated with inhibitors of either the MCU or ER-calcium
channel(s).
CONCLUSIONS
In conclusion, the emerging strategy put in action by HCV
is consistent with a fine rewiring of host cell metabolism.
This is achieved by depressing mitochondrial OxPhos while
fostering glycolysis which provides, in addition to energy,
precursors for biosynthetic processes. A major and perhaps
germinal event appears to be a deregulation of Ca2+ flux
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homeostasis between the ER and mitochondria at specialized
contact sites. This would selectively target mitochondria,
avoiding large changes of the Ca2+ concentration in the
cytosol, thus preserving cell viability. The ensued increase of
mtCa2+ leads to changes in the mitochondrial redox tone.
This results in progressive dysfunction of the respiratory chain
activity and the resulting OxPhos failure is bioenergetically
compensated by an enhanced glycolytic flux. In this context,
concurrent or consequent activation of prosurvival transcription
factors contributes to dampen cell death. Realization of
a membranous web constituted by accumulation of lipid
droplets, and possibly by incomplete mitophagy, provides a
suitable platform for HCV replication and virus particles
assembly. Depending on the prevailing conditions (i.e., the
level of the oxidative alterations and of the mtCa2+ load)
in such a multistep process, HCV infection can progress to
different clinical outcomes including steatosis, fibrosis, HCC
(Figure 4).
Importantly, the development of drugs selectively targeting
ER and/or mitochondrial calcium channels might represent a
potential strategy in support of standard HCV therapies.
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